Spyre Therapeutics Inc. (SYRE) institutional holders
Spyre Therapeutics Inc. 13F cache is empty on this URL.
No cached 13F holders for SYRE yet.
FAQ
What is SYRE P/E and revenue?
Spyre Therapeutics Inc. (SYRE) $7.60B cap.
Who owns SYRE?
No cached 13F holders for SYRE yet.
Not investment advice. Cached rows, not a live tape.